A recent study indicates that type 1 diabetes mellitus is associated with vascular brain lesions that affect cognition and might represent a target for preventive measures. This commentary discusses methods to ascertain vascular contributions to cerebral dysfunction in diabetes mellitus and indicates that we might only be seeing the tip of the iceberg.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Koekkoek, P. S., Kappelle, L. J., van den Berg, E., Rutten, G. E. & Biessels, G. J. Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol. 14, 329–340 (2015).
Biessels, G. J., Strachan, M. W., Visseren, F. L., Kappelle, L. J. & Whitmer, R. A. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2, 246–255 (2014).
Biessels, G. J. & Reijmer, Y. D. Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? Diabetes 63, 2244–2252 (2014).
Nelson, P. T. et al. Human cerebral neuropathology of type 2 diabetes mellitus. Biochim. Biophys. Acta 1792, 454–469 (2009).
Nunley, K. A. et al. White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes. Neurology 84, 2062–2069 (2015).
Barnea-Goraly, N. et al. Alterations in white matter structure in young children with type 1 diabetes. Diabetes Care 37, 332–340 (2013).
Mauras, N. et al. Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes 64, 1770–1779 (2015).
Wardlaw, J. M. et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 12, 822–838 (2013).
Wardlaw, J. M., Smith, C. & Dichgans, M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 12, 483–497 (2013).
Brundel, M. et al. Cerebral microvascular lesions on high-resolution 7-tesla MRI in patients with type 2 diabetes. Diabetes 63, 3523–3529 (2014).
Acknowledgements
G.J.B. would like to acknowledge the support of grant 2010T073 from the Dutch Heart Association and Vidi grant 91711384 from ZonMw, The Netherlands Organisation for Health Research and Development.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
G.J.B. consults for and receives research support from Boehringer Ingelheim and consults for Takeda Pharmaceuticals. Compensation for these services is transferred to his employer, the UMC Utrecht.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Biessels, G. Brain changes in T1DM—a microvascular complication?. Nat Rev Endocrinol 11, 447–448 (2015). https://doi.org/10.1038/nrendo.2015.93
Published:
Issue date:
DOI: https://doi.org/10.1038/nrendo.2015.93